|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/70 | (2006.01) |
| A61K 39/09 | (2006.01) |
| (11) | Number of the document | 3508579 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18211761.4 |
| Date of filing the European patent application | 2013-11-07 | |
| (97) | Date of publication of the European application | 2019-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-30 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261723408 P | 2012-11-07 | US |
| (72) |
WACKER, Michael , CH
KOWARIK, Michael , CH
WETTER, Michael , CH
FARIDMOAYER, Amirreza , CH
|
| (73) |
GlaxoSmithKline Biologicals SA ,
Rue de l'Institut, 89, 1330 Rixensart,
BE
|
| (54) | PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION |
| PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION |